SniffTrain: Effectiveness of Sniff Training in the Treatment of Post-Viral Anosmia

Part of paid clinical trials in Baltimore, Maryland.

Sponsor
University of Virginia
Study ID
NCT07857083
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Anosmia
  • Hyposmia
  • Post-viral Anosmia

Eligibility Criteria

Sex
ALL
Age
10 Years - 60 Years
Healthy Volunteers
Not accepted

Interventions

  • Sniff Training Kits — OTHER
    This study will test the ability of a structured smell training protocol (called "sniff training") to improved smell function. Participants will be asked to sniff inhaler cartridges containing different USDA GRAS (generally recognized as safe) odors (such as lemon, leather, strawberry, banana, etc). The amount of odor may differ, and odors may or may not be identified on the inhalers. The inhaler cartridge are provided at no charge to study participants in kits that contain four inhalers each.

Study Details

The purpose of this study is to learn whether a structured smell training program (called "sniff training") can help improve sense of smell and quality of life in people who have experienced a reduced or lost sense of smell following a viral illness (also called post-viral anosmia).

Key Dates

First listed
Oct 5, 2026
Start date
Jan 5, 2027
Status verified
Sep 2026
Primary completion
Jul 31, 2031
Completion
Jul 31, 2031

Study Design

Enrollment
204 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Arm 1: Sniffing named odors
    Participants randomly assigned to Arm 1 will receive sniff training kits containing four inhaler cartridges, with each cartridge containing a different odor (such as lemon, leather, rose, banana, etc). Odor names will be on the cartridges. Participants are instructed to sniff each inhaler cartridge in the morning and evening for 12 weeks. After this initial 12 weeks, participants will receive a new kit which may contain four different odors. These new inhaler cartridges will be sniffed for an additional 12 weeks. At several points in the study, participants will take smell tests or answer questionnaires to assess their ability to smell, their quality of life, and their psychological and neurological health.
  • Active Comparator: Arm 2: Sniffing unnamed odors
    Arm 2 will be identical to Arm 1 with the exception that the inhaler cartridges provided to participants randomly assigned to Arm 2 will not have labels identifying the aroma contained in each cartridge.
  • Other: Arm 3: Control Arm
    Arm 3 will be identical to Arm 2 with the exception that the inhaler cartridges will not contain the same amount of odor as in the inhaler cartridges used in Arm 2.

Primary Outcome Measure

Improvement in Odor Perception [ Time Frame: From enrollment to the end-of-study visit at 52 weeks ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
Johns Hopkins UniversityBaltimoreMaryland21218
Nicholas Rowan
443-997-6467
Nicholas Rowan (PRINCIPAL_INVESTIGATOR)
Medical University of South CarolinaCharlestonSouth Carolina29425
Rodney Schlosser
843-792-2300
Rodney Schlosser (PRINCIPAL_INVESTIGATOR)
University of VirginiaCharlottesvilleVirginia22903
Mackenzie Koch
434-531-5354
Steven Munger (PRINCIPAL_INVESTIGATOR)

Find similar trials in Baltimore, MD

Related Studies